Literature DB >> 18031363

Best candidates for capsule endoscopy for obscure gastrointestinal bleeding.

Zhi-Zheng Ge1, Hai-Ying Chen, Yun-Jie Gao, Yun-Biao Hu, Shu-Dong Xiao.   

Abstract

BACKGROUND AND AIM: Capsule endoscopy (CE) has an important role in the diagnosis of patients with obscure gastrointestinal bleeding. However, there was still controversy regarding the best candidates for CE. The present retrospective study aimed to access the best candidates for CE.
METHODS: There were 91 consecutive patients referred to the present study for 94 CE examinations from May 2002 to January 2005. They were divided into two groups (41 with active bleeding, and 50 with previous bleeding).
RESULTS: The CE findings were positive in 74.7%, suspicious in 11% of cases and negative in 14.3% of cases, respectively. The positive and suspected positive yield of CE were 75.6% and 19.5% in the active bleeding group, 74% and 4% in the previous bleeding group (P = 0.01), 75.7% and 21.6% in the overt bleeding group, 75% and 0% in the occult bleeding group (P = 0.206), 89.7% and 3.4% in patients who bled 2 weeks previously, 52.38% and 4.76% in patients who bled >2 weeks previously (P = 0.003), 75.6% and 19.5% in active bleeding group, 89.7% and 3.4% in patients who bled 2 weeks ago (P = 0.128).
CONCLUSIONS: The best candidates for the procedure are those with active bleeding, or active bleeding in the previous 2 weeks.

Entities:  

Mesh:

Year:  2007        PMID: 18031363     DOI: 10.1111/j.1440-1746.2006.04724.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Obscure gastrointestinal bleeding: single centre experience of capsule endoscopy.

Authors:  Carlo Calabrese; Giuseppina Liguori; Paolo Gionchetti; Fernando Rizzello; Silvio Laureti; Massimo Pierluigi Di Simone; Gilberto Poggioli; Massimo Campieri
Journal:  Intern Emerg Med       Date:  2011-09-29       Impact factor: 3.397

Review 2.  Evaluation and outcomes of patients with obscure gastrointestinal bleeding.

Authors:  Cositha Santhakumar; Ken Liu
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

3.  Single center experience of capsule endoscopy in patients with obscure gastrointestinal bleeding.

Authors:  Mahesh Kumar Goenka; Shounak Majumder; Sanjeev Kumar; Pradeepta Kumar Sethy; Usha Goenka
Journal:  World J Gastroenterol       Date:  2011-02-14       Impact factor: 5.742

4.  Factors associated with the clinical impact of capsule endoscopy in patients with overt obscure gastrointestinal bleeding.

Authors:  Motohiro Esaki; Takayuki Matsumoto; Shinichiro Yada; Ritsuko Yanaru-Fujisawa; Tetsuji Kudo; Shunichi Yanai; Shotaro Nakamura; Mitsuo Iida
Journal:  Dig Dis Sci       Date:  2009-12-03       Impact factor: 3.199

5.  Is there a role for emergency small bowel capsule endoscopy in the investigation and management of severe obscure-overt gastrointestinal bleeding?

Authors:  Edward J Despott
Journal:  Ann Gastroenterol       Date:  2013

Review 6.  The Role of Capsule Endoscopy in Patients with Obscure Gastrointestinal Bleeding.

Authors:  Yang Won Min; Dong Kyung Chang
Journal:  Clin Endosc       Date:  2016-01-28

Review 7.  Applications of wireless capsule endoscopy in pediatric age: an update.

Authors:  Fabiola Fornaroli; Federica Gaiani; Francesca Vincenzi; Barbara Bizzarri; Alessia Ghiselli; Stefano Kayali; Gioacchino Leandro; Francesco Di Mario; Gian Luigi De' Angelis
Journal:  Acta Biomed       Date:  2018-12-17

8.  The Optimal Timing for Using Capsule Endoscopy for Patients with Gastrointestinal Bleeding.

Authors:  Chao-Chin Chao; Lein-Ray Mo; Susan C Hu
Journal:  Biomed Res Int       Date:  2021-03-27       Impact factor: 3.411

9.  Is Occult Obscure Gastrointestinal Bleeding a Definite Indication for Capsule Endoscopy? A Retrospective Analysis of Diagnostic Yield in Patients with Occult versus Overt Bleeding.

Authors:  Ikue Watari; Shiro Oka; Shinji Tanaka; Makoto Nakano; Taiki Aoyama; Shigeto Yoshida; Kazuaki Chayama
Journal:  Gastroenterol Res Pract       Date:  2013-11-12       Impact factor: 2.260

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.